As ophthalmologists, we rely daily on the interplay between light and tissue to diagnose and treat complex pathologies. At the heart of our most essential imaging modalities lies the principle of fluorescence—a type of luminescence where specific molecules, or fluorophores, absorb high-energy light and emit light of a longer wavelength (lower energy) as they return to their ground state. This shift is what allows us to visualize the intricate details of the ocular fundus and the ocular surface.
The Gold Standard: Sodium Fluorescein
Sodium fluorescein remains the cornerstone of retinal vascular imaging. With an excitation peak near 490 nm (blue light) and an emission peak around 514 nm (green light), it boasts an incredibly high quantum yield of up to 0.95.
Historical Perspective: The introduction of fluorescein angiography (FA) is widely credited to two medical students, Harold Novotny and David Alvis, in 1961. Interestingly, their seminal work was initially rejected by the American Journal of Ophthalmology and was instead published in the journal Circulation. Their findings were preceded by feline studies at Stanford by Chao, Flocks, and Miller in the late 1950s.
Clinical Considerations:
- Vascular Dynamics: Its low molecular weight (376 g/mol) allows it to diffuse easily when the blood-retinal barrier is compromised.
- Safety: Classified as FDA Pregnancy Category C, it should only be used during pregnancy when absolutely necessary, though no well-controlled studies have demonstrated human fetal complications.
- Routes of Administration: While IV is standard, oral administration is a viable alternative for patients with poor venous access or those who cannot tolerate injections, such as children.
Visualizing the Deep: Indocyanine Green (ICG)
While fluorescein is ideal for the retina, indocyanine green (ICG) is essential for the choroid. Developed for ophthalmic use by Flower and associates in 1971, ICG was initially met with resistance due to early technological limitations and high costs.
Why the Choroid? ICG absorbs light at 780 nm and emits at 810 nm. Because near-infrared light undergoes significantly less scatter than shorter wavelengths—blue light is scattered approximately 7 times more than near-infrared light—ICG can penetrate the retinal pigment epithelium (RPE) to reveal deep choroidal vessels.
Key Applications:
- Diagnosis: It is indispensable for identifying inflammatory lesions in sarcoidosis and birdshot retinochoroidopathy (appearing as hypofluorescent spots), as well as characterizing choroidal hemangiomas and central serous chorioretinopathy.
- Biomarker for Amyloid: Recent research suggests late-phase ICG staining (around 15 minutes) is a promising biomarker for transthyretin amyloid, with staining levels correlating to systemic involvement.
- Surgical Use: ICG is frequently used to stain the internal limiting membrane (ILM) during vitreoretinal surgery.
- Terminology Note: The term “cyanescence” is often used in literature to describe ICG images, but it is a misnomer; the process is strictly fluorescence, and “hyper/hypofluorescence” are the accurate terms.
Beyond Imaging: Therapeutic Fluorophores
Fluorophores are not just for diagnostics; they have significant therapeutic roles:
- Riboflavin (Vitamin B2): When applied to the cornea and activated by ultraviolet light, riboflavin produces reactive free radicals that cross-link corneal collagen, effectively stopping the progression of keratoconus.
- Rose Bengal: Known for staining degenerating epithelial cells, this fluorophore can be activated into a photoreactive species to treat aggressive corneal infections, including Acanthamoeba and fungal keratitis.
- Indocyanine Green (Photothermal): Approximately 88% of the infrared light absorbed by ICG is converted to thermal energy, a property used in the photothermal treatment of retinal and choroidal tumors.
The Future: Amyloid and Alzheimer’s
The next frontier for ophthalmic fluorophores may be the early diagnosis of systemic disease. Curcumin, isolated from turmeric, has a binding affinity for amyloid species. As evidence grows that amyloid deposits in the retina as well as the brain, low-cost imaging techniques using curcumin congeners could revolutionize how we screen for and monitor Alzheimer’s disease.
Conclusion
From the historic work of medical students in 1961 to the cutting-edge use of curcumin for neurodegenerative disease, fluorophores continue to define the boundaries of what we can see and treat in ophthalmology. Maintaining a precise understanding of their physical properties and using accurate terminology is essential for both clinical excellence and the advancement of research.
Citations: Kaiser, Alexis, et al. “A REVIEW OF FLUORESCEIN ANGIOGRAPHY, INDOCYANINE GREEN ANGIOGRAPHY, AND OTHER FLUOROPHORES IN OPHTHALMOLOGY.” Retina, vol. 46, no. 6, 1 June 2026, pp. 49-53, doi:10.1097/IAE.0000000000004727.
